MindWalk Holdings (HYFT) Net Margin Growth (1y) (2021 - 2026)

MindWalk Holdings (HYFT) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -185.00
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn -763.00
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 447.00
4 Revolution Medicines 43.64 Bn 43.64 Bn - -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 673.00
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 3,097.00
7 Royalty Pharma 33.72 Bn 35.84 Bn - -392.00
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 2,208.00
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 29,636.00
10 Roivant Sciences 26.16 Bn 26.85 Bn 1.16 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2026 -2.00
Oct 31, 2025 -3,710.00
Jul 31, 2025 3.57 Mn
Apr 30, 2025 -48,253.00
Jan 31, 2025 -2,122.00
Oct 31, 2024 -2.87 Mn
Jul 31, 2024 -7.33 Mn
Apr 30, 2024 127,468.00
Jan 31, 2024 1,662.00
Oct 31, 2023 2.86 Mn
Jul 31, 2023 7.33 Mn
Apr 30, 2023 -41,975.00
Jan 31, 2023 2,480.00
Oct 31, 2022 21,520.00
Jul 31, 2022 7,714.00
Apr 30, 2022 9.28 Bn
Jan 31, 2022 2,668.00
Oct 31, 2021 -5,826.00
Jul 31, 2021 -3,360.00